{"id":13864,"date":"2026-06-11T17:59:04","date_gmt":"2026-06-11T17:59:04","guid":{"rendered":"https:\/\/medical-article.com\/?p=13864"},"modified":"2026-06-11T17:59:04","modified_gmt":"2026-06-11T17:59:04","slug":"novartis-rna-med-from-12b-deal-keeps-building-case-to-become-first-therapy-for-rare-muscle-disease","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=13864","title":{"rendered":"Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/06\/novartis-fshd-muscular-dystrophy-dux4-rna-genetic-medicine-neuroscience-aoc-nvs\/\"><\/a><\/p>\n<p>Novartis said its RNA therapy del-brax met goals of a Phase 1\/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis\u2019s $12 billion acquisition of Avidity Biosciences.<\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/06\/novartis-fshd-muscular-dystrophy-dux4-rna-genetic-medicine-neuroscience-aoc-nvs\/\">Novartis RNA Med From $12B Deal Keeps Building Case to Become First Therapy for Rare Muscle Disease<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Novartis said its RNA therapy del-brax met goals of a Phase 1\/2 study in facioscapulohumeral muscular dystrophy (FSHD), an inherited muscle disorder that currently has no FDA-approved medicines. Del-brax is one of three RNA therapies from Novartis\u2019s $12 billion acquisition of Avidity Biosciences. The post Novartis RNA Med From $12B Deal Keeps Building Case to&#8230;<\/p>\n","protected":false},"author":0,"featured_media":13865,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-13864","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13864"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13864"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/13864\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/13865"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}